Abstract
The genus Naegleria is a taxonomic subfamily consisting of 47 free-living amoebae. The genus can be found in warm aqueous or soil habitats worldwide. The species Naegleria fowleri is probably the best-known species of this genus. As a facultative parasite, the protist is not dependent on hosts to complete its life cycle. However, it can infect humans by entering the nose during water contact, such as swimming, and travel along the olfactory nerve to the brain. There it causes a purulent meningitis (primary amoebic meningoencephalitis or PAME). Symptoms are severe and death usually occurs within the first week. PAME is a frightening infectious disease for which there is neither a proven cure nor a vaccine. In order to contain the disease and give patients any chance to survival, action must be taken quickly. A rapid diagnosis is therefore crucial. PAME is diagnosed by the detection of amoebae in the liquor and later in the cerebrospinal fluid. For this purpose, CSF samples are cultured and stained and finally examined microscopically. Molecular techniques such as PCR or ELISA support the microscopic analysis and secure the diagnosis.
Infectious diseases continue to be a major cause of illness and death, especially in poorer countries of the global South [1]. The pathogens that cause these diseases are diverse and rich in form. Alongside viruses and bacteria, parasites represent the third major pathogen caste of disease-causing agents [2]. Parasites occur, for example, in the form of intestinal worms or unicellular eukaryotes, so-called protists. Many dangerous and relevant diseases are caused by such protists. For example malaria, sleeping sickness, or Chagas disease. Many are dangerous tropical diseases that are relevant to travellers of the temperate countries of the global west [3] (Fig. 1).
The systematic classification of the protists is unclear and is subject to regular changes and adaptations. It is clear that protists are not a systematic clade in the strict sense [4, 5]. In some cases, they are referred to as algae [6]. Due to this diversity of forms, a meaningful classification that is relevant for targeted science is not easy. One possible classification focuses on the type of movement. Different protists have evolved different modes of locomotion: with cirripedes, cilia, flagella or as amoebae with pseudopodia [7]. Since the classification, like other types of protist characterization, focuses purely on external features and morphologies, there is no relationship within these classifications. Pathogens can be found in all of these classifications. For example, the causative agents of sleeping sickness and Chagas disease are distinguished by their characteristic flagella [8] (Fig. 2).
This article deals with a different group of protists: the amoebae. Although amoebae may also cause dangerous diseases, they are overshadowed by other protist infections such as malaria, toxoplasmosis or Chagas disease.
Amoebae are also not a systematic clade, but a life form. Amoebae are unicellular organisms without a fixed body shape that are not closely related to each other. They move by the formation of so-called pseudopods. In doing so, the amoebae change their body shape [9]. At up to 1 mm, they belong to the largest protists. Some groups are shelled (Thecamoebae), but most are naked [10]. Amoebae feed heterotrophically via phagocytosis or autotrophically via photosynthesis. For this purpose, the autotrophic amoebae possess chloroplasts [11].
Amoebae are be found worldwide, including the Arctic and Antarctic [12]. Amoebae can also survive in airless space. For this purpose, they form cysts. However, most amoebae prefer moist soils and mud as well as water (fresh and salt water) [13]. The life form of the amoeba has evolved independently several times in evolutionary terms. In modern systematics, heterotrophic amoebae are usually classified as Amoebozoa, Rhizaria, and Excavata. Autotrophic forms usually belong to the group Chromalveolata [14, 15].
Many amoebae are pathogens for humans and can sometimes cause serious illnesses. One of the best known is probably amoebic dysentery. This is a severe gastrointestinal disease that causes, among other things, bloody, slimy diarrhea [16, 17]. Amoebic dysentery is caused by the entamoeba Entamoebe histolytica [18]. With approximately 50 million cases per year, amoebic dysentery is one of the most common protozoan infections [19,20,21]. Acanthamoebae can lead to severe inflammation of the cornea, especially in contact lens wearers [22]. For this reason, contact lenses should be cleaned regularly and the contact lens solution should also be changed regularly. Acanthamoeba keratitis is easy recognized and treat [23]. Amoebae can also cause inflammation in the oral cavity. Entamoeba gingivalis usually occurs in persistent gingivitis [24, 25]. In addition, amoebae can also serve as reservoir for pathogenic bacteria [26].
Much rarer than amoebic dysentery, but also much more extreme, is the so-called PAME. PAME stands for primary amoebic meningoencephalitis, a purulent inflammation of the brain. The associated pathogen is Naegleria fowleri [27].
Naegleria fowleri is a species of the genus Naegleria, which includes about 50 species. Naegleria belongs to the Tetramitia, the largest group of Heterolobosea, which groups together amoeboid protozoa. The Heterolobosea belong to the Excavata, one of the three eukaryotic supergroups [28, 29]. In this context, the Excavata are the only supergroup that is exclusively unicellular [30]. The remaining two, the Diaphoretickes and the Amorphea contain both unicellular and multicellular organisms. The Diaphoretickes include plants [31]. The Amorphea include fungi and animals [32]. The Excavata are divided into 7 groups without systematic rank: the Fornicata, the Malawimonas, the Parabasalia, the Preaxostyla, the Jakobida, the Euglenozoa and the Heterolobosea [30]. Species of the genus Naegleria are dependent on moisture and thus are found in moist soil as well as in stagnant water [33]. As it can spread optimally in warm waters, it can be found in swimming pools, bathing lakes and industrial wastewater [34]. Its distribution is not regionally limited. N. fowleri has been detected worldwide. Focal populations are found in the USA, Australia and France [35, 36]. Under ideal conditions, the trophozoites of N. fowleri form large colonies [37]. The trophozoite represents the amoeboid form. As a trophozoite, N. fowleri forms pseudopodia and feeds on bacteria and detritus. However, if the environmental parameters change, for example due to a drop in electrolyte levels, the cell forms flagella in order to escape quickly. If the parameters deteriorate further or escape is not possible, N. fowleri forms cysts. This cyst form is the smallest form with a size of up to 15 µm. The trophozoite is twice as large at 30 µm [38]. Figure 3 shows the different stages of the amoeba's life cycle.
Naegleria fowleri is a so-called facultative parasite. This means that, unlike other parasites, the amoeba does not require a host for its life cycle. Like other Naegleria species, N. fowleri reproduces via mitosis [36].
Naegleria is interesting from a molecular point of view. This is because the cell is capable of transforming from an amoeboid form without a cytoskeleton to a flagellate form with complex cytoskeletal structures and flagella. The mechanism is the subject of research. Naegleria gruberi has been established as a model in this respect. Although N. gruberi is very closely related to N. fowleri, it is not a pathogen and thus its safe for researchers [39, 40]. N. gruberi is the only Naegleria species whose genome has been completely sequenced. Medicine could also benefit from this research. For example, the conversion from the amoeboid type to the flagellate type or the associated mechanism (including the de novo synthesis of centrioles) could be a theoretical target of therapeutics [41,42,43]. In practice, however, this is considerably complicated by the status of N. fowleri or PAME as a neglected disease [35]. In general, there is no therapeutic need for this disease, although indescribably tragic for the individual patient. The reason for this is the rarity of the cases.
Route of infection
As already described, N. fowleri is a facultative parasite. This means that, unlike other protozoa such as Plasmodium spp. or Toxoplasma gondii, N. fowleri is not dependent on humans as hosts to complete its life cycle and thus reproduce [36, 44, 45]. Nevertheless, N. fowleri is capable of infecting humans and causing severe disease. In this case, infection occurs exclusively through the nose. If contaminated water is drawn up the nose, for example, during diving or when the head is held under water, N. fowleri cells can enter the brain via the olfactory nerve (Nervus olfactorius) [27, 36, 40]. Sources of infection are contaminated water sources such as lakes or swimming pools [37, 44] (see Fig. 4). Infections at home are also described less frequently. For example, via contaminated tap water [46, 47] or nasal rinsing [48]. This may also play a role in religious cleansing rituals [49, 50].
N. fowleri cannot be ingested via the oral route. Ingestion of contaminated water is therefore not dangerous [51, 52]. Infections via water vapor or droplets have also not been reported [53, 54]. As N. fowleri is very resistant, treatment of water, for example, with chlorine, is only of limited help [55]. However, wearing nose clips while swimming can significantly reduce the risk [56, 57]. Transmission between humans is not possible. This includes organ transplants. These have been discussed as a possible route of transmission for some time. However, transmission through transplantation has not been confirmed [58, 59] (Fig. 5).
Disease and Symptoms
If N. fowleri reaches the brain, the parasite causes a purulent meningitis. This meningitis is referred to in the clinic and in the literature as either primary amoebic meningoencephalitis (PAME or PAM), Naegleriasis or swimming pool amoebosis. The first symptoms usually appear between three and seven, but not later than 14 days, after exposure [45, 54]. The onset of symptoms is immediately and severe. At the beginning of the disease phase, PAME is characterized by severe nausea with vomiting, high fever, headache, and neck stiffness [60, 61]. The second phase is characterized by a pyogenic meningoencephalitis (the development of pus is called pyogenesis) and coma eventually occur [44, 45, 62]. Death occurs one week after the onset of symptoms. PAME mainly affects children and young adults. Therefore, similar to malaria, PAME can be considered a dangerous childhood disease [44, 62, 63]. However, infections with Naegleria fowleri are significantly rarer than with Plasmodium spp. About 400 cases are reported in the literature per year (381 PAM cases in 2018). Patients are usually male (75%) and have an average age of 14 years. In the US, 16 cases are reported for 2018, including 8 male and 8 female patients. All of these cases were fatal. PAME is considered extremely fatal. In the USA, of 157 documented cases between the years 1962 and 2022, only four patients survived [64,65,66,67]. N. fowleri is classified as a neglected (tropical) disease [35]. These NTDs include infectious diseases that are fatal and/or very dangerous, but not as focused on as other infectious diseases (neglected). The reason for this neglect can be manifold. For example, many neglected diseases play an important medical role in poorer countries of the global south. The health systems in these countries need to be expanded and are often dependent on donations from non-governmental organizations of development aid. As a result of this donation system, the financial resources required for research and treatment of these neglected diseases are often lacking. The lack of trained specialists is also a reason for this neglect [68]. N. fowleri is not reportable [66].
Immunity
As there is still no reliable drug therapy against N. fowleri, understanding the immune response is important for research and the development of new drugs and therapeutics. As the infection is fatal in humans, immunologists rely on animal models.
Innate Immune Response
Studies have shown that the infiltration of the amoeba cells in the nose occurs with little inflammation. This initial infiltration is in stark contrast to the aggressive inflammation that occurs later in the brain. The lethal inflammatory reaction ultimately results from the discovery and subsequent infiltration of immune cells (neutrophils, eosinophils, monocytes and macrophages) into the brain tissue [69]. The lack of an inflammatory response upon infiltration of the nasal tissue with subsequent strong reactions in the brain indicates that the amoebae have a way to bypass the innate immune response and invade the tissue undetected [70]. In contrast to bacterial and viral infections, the detection of protists by the immune system is more difficult. Since the cells of the pathogen are eukaryote just like the host cells, they are often recognized as non-foreign by the pattern recognition ability of the immune system [71]. Infections with amoebae can lead to increased activity of neutrophil granulocytes via antibody-mediated complement activation. However, studies show that N. fowleri have a certain resistance to the lysis mediated by this cascade. Only limited evidence shows that the complement system is relevant for immunology against N. fowleri [72].
In the host, N. fowleri feeds by trogocytosis, similar to how immune cells interrogate antigens from antige-presenting cells [73]. It can be assumed that this behavior puts the body cells under strong stress, which could, for example, lead to a strong release of substances like ATP [74]. However, there is little data on this approach. The situation is better when it comes to researching cytokines and their role in the immune response to N. fowleri. Tumor necrosis factor alpha (TNFα) probably plays an important role. This activates neutrophil cells, which in turn attack the amoebae. Important mechanisms of this attack are probably related to enzymes such as myeloperoxidase, superoxide formation or the release of so-called extracellular traps [75, 76]. Studies with animal models show that TNFα also plays a crucial role in the control of the disease and the development of PAM. Animals injected with TNFα did not develop PAM, even after the onset of the disease [77]. This knowledge is of particular importance for the development of new therapies. However, there are still many unanswered questions. For example, it is still unclear how the activated neutrophils detect the amoebae in the tissue and launch a coordinated attack. Individual neutrophil cells cannot tackle an N. fowleri amoeba with success [78].
Innate Immune Response
The study of the adaptive immune response to N. fowleri infections is difficult due to the rapid lethal course. Surface-binding antibodies can be rapidly taken up by N. fowleri [79]. Thus, the amoeba can undermine the humoral immune response to a certain degree. However, since antibodies to a certain degree. However, since antibodies are constantly produced in vivo, this uptake is inhibited at some point. Immunization strategies experimenting with different antigens and cell states (amoeba lysate, living amoebae, fixed amoebae, specific proteins) showed that circulating antibodies are the main immune mechanism of the adaptive immune response [79]. The intrathecal administration of therapeutic monoclonal antibodies was able to prolong the survival of animal models. Antibodies affect N. fowleri in various ways. They can opsonize the cells and thus facilitate phagocytosis or effector activity. However, many antibodies against N. fowleri are directed against internal cell structures and do not target surface proteins [80]. During acute infection, IgM is produced by the immune cells. IgM is also used in infection with N. fowleri and can trigger agglutination and complement activation. However, IgM has difficulty to cross the blood–brain barrier due to its large molecular weight (approx. 900kD) [69].
In addition to the problem of the large molecular weight, other factors can negatively influence IgM. For example, various surface antigens of amoebic cells can promote T-independent reactions. Similar reactions can also be observed with certain bacterial polysaccharides [81]. Other factors that can favour an IgM bias are defects in the Naegleria-specific CD4 + repertoire of T Cells, defects in priming and defects in the functions that facilitate antibody class switching. In general, research into the innate immune response is still incomplete. Amoeba-specific CD4 + T cell functionality has bot been carefully studied for N. fowleri either after infections or for potential vaccines [82]. And although it has been observed that cell-mediated immunity against N. fowleri is associated with a time-delayed hypersensitivity, however, the need for research is still quite high. In animal models, it has been observed that IL-4 concentration is associated with animal survival. This may be relevant for vaccination research. As this effect is strongly dependent on STAT6 (Signal Transducer and Activator of Transcription 6), it can be assumed that Th2 cells play an important role in this process. STAT6 is essential for the signalling pathway that is responsible for the formation of Th2 cells and the associated immune response [83].
Pathology and Diagnosis
In diagnostics, a fundamental distinction must be made between two temporal examinations: the premortem and the postmortem examination. The former serves the clinical diagnosis of the patient by using microscopic and molecular methods, the latter includes the autopsy and associated macroscopic examinations of the affected (brain) tissue [66].
Since the occurring symptoms are strong, but also quite unspecific. A precise diagnostic clarification is imperative. Pyogenic meningoencephalitides can have various causes, for example brain tumors or abscesses. Bacterial or viral encephalitides also cause almost identical symptoms. These conditions should be considered in the differential diagnosis. On the other hand, PAME should also be considered in cases of encephalitides that have not been further investigated (here, the travel history can also play an important role as a special part of the medical history). The diagnosis is made after microscopic and molecular examination. Molecular techniques include PCR and ELISA. There is a multiplex PCR that can be used to detect Acanthamoebae, N. fowleri and B. mandrillaris in combination [66, 84].
Macroscopy
Due to the aggressiveness and lethality of PAME, the pathological macroscopic examination can only be performed postmortem at the necropsy. This examination is primarily necessary to confirm or exclude “Naegleria fowleri/PAME” as the cause of death. The macroscopic examination is carried out by neuropathologists by examining the brain. PAME appears on the brain in the form of severe hemorrhages and associated necrosis of brain tissue. The hemorrhages are mainly localized in the frontal cortex. The Figs. 6 and 7 show an affected brain. The tissue is typically further examined by microscopy and molecular biological methods [66].
Microscopy and Histology
A microscopic examination is mandatory. As with other parasitic infections, it is the gold standard here and allows the detection of not only N. fowleri, but also other amoeba species. In this way, the diagnosis can be further narrowed down. Microscopic samples of the patients' cerebrospinal fluid are taken. These are obtained from the nose. A histological examination of the tissue of the Bulbus olfactorius is also permitted. The specimens can be stained. Examination after cultural cultivation is also common. Here it should be noted that the sample material is not frozen and is kept moist with a few drops of water. Otherwise, the amoebae could die. PAME is considered diagnosed when fast-moving sporozoites of N. fowleri are found. Molecular studies could confirm or further narrow down the species. A distinctive feature that can be exploited in the diagnosis of N. fowleri is its ability to differentiate cells. In hypotonic water, N. fowleri transforms into its flagellate form within two hours. This allows N. fowleri to be reliably diagnosed, as other pathogens do not have this ability [66, 85, 86] (see Figs. 8 and 9).
Therapy
There is still no proven therapy that can be used for N. fowleri. Based on various laboratory studies and case studies, the Centers for Disease Control and Prevention recommends treatment with amphotericin B, which should be used in high doses. Amphotericin B is traditionally an antifungal agent used for severe fungal infections, but it is also used in the treatment of parasitic leishmaniasis. Amphotericin B should be administered intrathecally [66, 87,88,89].
Various studies examined the use of combined medications. In addition to amphotericin B, the drugs used in the studies also included fluconazole, chloramphenicol, dexamethasone, miconazole, rifampicin and miltefosine [90]. The success of the studies remained modest. A cure is very rarely. The studies showed that the effects are greatest when the drugs are administered early after exposure. The sooner the better. However, this is complicated by the rapid progression of the disease in conjunction with the diagnostic process. Another problem with the studies is that many effects have only described in vitro. Last but not least, the use in in vivo studies is ethically complex [90,91,92].
Miltefosine was used in some later cases [89, 93, 94]. It was shown that the success of the therapy was closely related to therapeutic temperature management (TTM) [95, 96]. The goal of TTM, also known as therapeutic hypothermia, is to lower and maintain a specific body temperature over a period of time [96]. Since N. fowleri attacks the brain, it is also important to pay attention to possible neurological damage during therapy. The effect of miltefosine on the central nervous system has also not been conclusively clarified. In 2013, a 12-year-old girl was successfully treated with miltefosine in combination with TTM. She survived the infection without neurological sequelae. However, the reason for this success was undoubtedly also the rapid diagnosis and intervention. At the same time, an 8-year-old boy was also treated with miltefosine. However, in his case TTM was omitted. He also survived, but with (probably) lifelong neurological damage. In 2016, the 12-year-old's therapy was successfully repeated in a 16-year-old male patient. This patient also survived without neurological damage. He himself simply states that learning has become more difficult for him in general [97].
In 2023, new results were published showing that treatment with benzoxaborole significantly improved life expectancy in infected mice and led to partial (28%) cure [98].
Recently, a new class of drugs and therapies has been emerging. As many anti-inflammatory agents are becoming outdated due to their sometimes severe side effects, new classes of agents are of particular interest [99]. These include the so-called anti-heterocyclic compounds. The synthesis of these active substances is accompanied by a number of advantages. Not only are they comparatively cheap to synthesize. They also have a wide range of pharmacological qualities. Studies have confirmed their antiviral, antibacterial, anticancer and insecticidal effects. Modern medical research also benefits from nanotechnology [100]. Silver nanoparticles (SNPs), for example, are of interest. In nanotechnology, materials are modified at atomic level. SNPs can be used to activate carbon composites. This is done by favourable photodeposition. This produces pure, well-defined SNPs. In addition to other uses, they play an important role as therapeutics agents. For example, as reagents and precursor for various formulations against COVID-19 or cancer. They can also be used as antioxidants [101, 102]. Novel substances such as these are also interesting for parasitology. Studies have already confirmed positive effects against malaria and other parasitic infections [103]. Drugs used against N. fowleri showed better effects when they were previously conjugated with silver nanoparticles. This was the case for nystatin and amphotericin B, but not for fluconazole. The researchers hope that this modification will enhance the effect of existing drugs to such an extent that the development of new drugs (which also involves investing a lot of money) will become at least partially obsolete [104].
It is questionable how likely the development of a vaccine against N. fowleri is. Due to the rarity of the disease, it is not the focus of profit-oriented pharmaceutical companies. Nevertheless, there are a few publications that deal with possible vaccines against the amoebae. In 2023, a research group from Mexico investigated the immunoprotected influence of two antigens. One of these antigens is the membrane protein MP2CL5 (Smp145). Both were injected intranasally into BALB/c mice. Cholera toxin (CT) served as an adjuvant. According to the study results, the antigens achieved a protection of 80–100%, respectively. In addition, a significant increase in T and B lymphocytes was observed. MP2CL5 is currently considered a promising candidate for a vaccine against N. fowleri [105]. In addition, research into N. fowleri also benefits from the new mRNA vaccines. mRNA vaccines against N. fowleri are already being discussed and in some cases have already been researched. In addition to feasibility, the location of the vaccination site is also part of these discussions. As a rule, the extremities are vaccinated: the arm or, in young children, in the leg. Intranasal vaccinations, i.e. vaccinations in the nose, have already been discussed for SARS-CoV-2 [106]. Since it is known that its tissue-specific exposure controls the immune system, intranasal vaccinations against N. fowleri are particularly interesting. After all, this is the first time the amoeba encounters the host tissue. Nevertheless, the development of a potent vaccine against N. fowleri remains questionable at the moment. Not least because of its rarity.
Outlook and Conclusion
Because of its lethal consequences and speed, PAME is a serious disease. For this reason, the diagnosis can also be very frightening and stressful for patients. In conclusion, the prevalence of N. fowleri should be considered in the context of climate change. The prevalence of the amoeba is thought to change with increasing climate and is likely to become more important [107]. This assumption is supported by existing epidemiological data. Cases have been increasing since 2000 [108]. This also shows an increasing range in the geographical area as well as in the age of the patients. Simply put, N. fowleri is occurring more frequently in the elderly people in more countries. It should also be noted that in India, for example, cases occur more frequently that are not water-related, i.e., do not result from swimming. How exactly these cases arose is still unclear [108]. However, they point out that N. fowleri poses an increasing threat as climate changes and should be considered in the context of climate change. Its status as an NTD complicates important developments (both in science and in (health) policy). This could become a problem in the near future. The right course should therefore be set quickly.
References
Murray CJ, Lopez AD (1997) Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 349:1436–1442
Dehio C, Berry C, Bartenschlager R (2012) Persistent intracellular pathogens. FEMS Microbiol Rev 36:513
Löscher T, Salzberger B (2014) Reisemedizin. Internist 55:245
Adl SM, Simpson AGB, Farmer MA, Andersen RA, Anderson OR, Barta JR, Bowser SS, Brugerolle G, Fensome RA, Fredericq S, James TY, Karpov S, Kugrens P, Krug J, Lane CE, Lewis LA, Lodge J, Lynn DH, Mann DG, McCourt RM, Mendoza L, Moestrup O, Mozley-Standridge SE, Nerad TA, Shearer CA, Smirnov AV, Spiegel FW, Taylor MFJR (2005) The new higher level classification of eukaryotes with emphasis on the taxonomy of protists. J Eukaryot Microbiol 52:399–451
Burki F, Roger AJ, Brown MW, Simpson AGB (2020) The new tree of eukaryotes. Trends Ecol Evol 35:43–55
Bamforth SS (1981) Protist biogeography. J Protozool 28:2–9
Cavalier-Smith T (2013) Early evolution of eukaryote feeding modes, cell structural diversity, and classification of the protozoan phyla Loukozoa, Sulcozoa, and Choanozoa. Eur J Protistol 49:115–178
Krüger T, Engstler M (2015) Flagellar motility in eukaryotic human parasites. Semin Cell Dev Biol 46:113–127
Pawlowski J, Burki F (2009) Untangling the phylogeny of amoeboid protists. J Eukaryot Microbiol 56:16–25
Rogerson A (1993) Parvamoeba rugata n. g., n. sp., (Gymnamoebia, Thecamoebidae): an exceptionally small marine naked amoeba. Eur J Protistol 29:446–452
Gabaldón T, Völcker E, Torruella G (2022) On the biology, diversity and evolution of nucleariid Amoebae (Amorphea, Obazoa, Opithokonta1. Protist 173:125895
Tyml T, Skulinová K, Kavan J, Ditrich O, Kostka M, Dyková I (2016) Heterolobosean amoebae from Arctic and Antarctic extremes: 18 novel strains of Allovahlkampfia, Vahlkampfia and Naegleria. Eur J Protistol 56:119–133
Rohr U, Weber S, Michel R, Selenka F, Wilhelm M (1998) Comparison of free-living amoebae in hot water systems of hospitals with isolates from moist sanitary areas by identifying genera and determining temperature tolerance. Appl Environ Microbiol 64:1822–1824
Gräf R, Batsios P, Meyer I (2015) Evolution of centrosomes and the nuclear lamina: amoebozoan assets. Eur J Cell Biol 94:249–256
Caron DA, Hu SK (2019) Are we overestimating protistan diversity in nature? Trends Microbiol 27:197–205
Lejeune M, Rybicka JM, Chadee K (2009) Recent discoveries in the pathogenesis and immune response toward Entamoeba histolytica. Future Microbiol 4:105–108
Pantzaris N, Tank V, O’Meara D, Chiodini P, Lim F, Martin V, Thi AA (2022) P53 Entamoeba histolytica testing in the management of inflammatory bowel disease patients at university hospitals Leicester. Gut 71:A65–A65
Dhubyan Mohammed Zaki Z (2022) Prevalence of Entamoeba histolytica and Giardia lamblia associated with diarrhea in children referring to Ibn Al-Atheer Hospital in Mosul. Iraq Arch Razi Inst 77:73–79
Clark CG (1998) Royal society of tropical medicine and hygiene meeting at Manson House, London, 19 February 1998. Amoebic disease Entamoeba dispar, an organism reborn. Trans R Soc Trop Med Hyg 92:361–364
Carrero JC, Reyes-López M, Serrano-Luna J, Shibayama M, Unzueta J, León-Sicairos N, de la Garza M (2020) Intestinal amoebiasis: 160 years of its first detection and still remains as a health problem in developing countries. Int J Med Microbiol 310:151358
Quispe-Rodríguez GH, Wankewicz AA, Málaga Granda JL, Lewis B, Stockert K, White AC Jr (2020) ´Entamoeba histolytica´ identified by stool microscopy from children with acute diarrhoea in Peru is not E. histolytica. Trop Doct 50:19–22
Stapleton F (2020) Contact lens-related corneal infection in Australia. Clin Exp Optom 103:408–417
Kaufman AR, Tu EY (2022) Advances in the management of Acanthamoeba keratitis: a review of the literature and synthesized algorithmic approach. Ocul Surf 25:26–36
Bao X, Wiehe R, Dommisch H, Schaefer AS (2020) Entamoeba gingivalis causes oral inflammation and tissue destruction. J Dent Res 99:561–567
Santos JO, Roldán WH (2023) Entamoeba gingivalis and Trichomonas tenax: Protozoa parasites living in the mouth. Arch Oral Biol 147:105631
Jeon KW (2004) Genetic and physiological interactions in the amoeba-bacteria symbiosis. J Eukaryot Microbiol 51:502–508
Güémez A, García E (2021) Primary amoebic meningoencephalitis by Naegleria fowleri: pathogenesis and treatment. Biomolecules 11:1320
Park JS, Simpson AGB, Lee WJ, Cho BC (2007) Ultrastructure and phylogenetic placement within Heterolobosea of the previously unclassified, extremely halophilic heterotrophic flagellate Pleurostomum flabellatum (Ruinen 1938). Protist 158:397–413
Pánek T, Ptáčková E, Čepička I (2014) Survey on diversity of marine/saline anaerobic Heterolobosea (Excavata: Discoba) with description of seven new species. Int J Syst Evol Microbiol 64:2280–2304
Peña-Diaz P, Lukeš J (2018) Fe-S cluster assembly in the supergroup Excavata. J Biol Inorg Chem 23:521–541
Lax G, Eglit Y, Eme L, Bertrand EM, Roger AJ, Simpson AGB (2018) Hemimastigophora is a novel supra-kingdom-level lineage of eukaryotes. Nature 564:410–414
Brown MW, Heiss AA, Kamikawa R, Inagaki Y, Yabuki A, Tice AK, Shiratori T, Ishida KI, Hashimoto T, Simpson AGB, Roger AJ (2018) Phylogenomics places orphan protistan lineages in a novel eukaryotic super-group. Genome Biol Evol 10:427–433
Stahl LM, Olson JB (2020) Environmental abiotic and biotic factors affecting the distribution and abundance of Naegleria fowleri. FEMS Microbiol Ecol 97:fiaa238
Huizinga HW, McLaughlin GL (1990) Thermal ecology of Naegleria fowleri from a power plant cooling reservoir. Appl Environ Microbiol 56:2200–2205
Martínez-Castillo M, Cárdenas-Zúñiga R, Coronado-Velázquez D, Debnath A, Serrano-Luna J, Shibayama M (2016) Naegleria fowleri after 50 years: is it a neglected pathogen? J Med Microbiol 65:885–896
Zhang H, Cheng X (2021) Various brain-eating amoebae: the protozoa, the pathogenesis, and the disease. Front Med 15:842–866
Esterman A, Roder DM, Cameron AS, Robinson BS, Walters RP, Lake JA, Christy PE (1984) Determinants of the microbiological characteristics of South Australian swimming pools. Appl Environ Microbiol 47:325–328
Evdokiou A, Marciano-Cabral F, Jamerson M (2022) Studies on the cyst stage of Naegleria fowleri in vivo and in vitro. J Eukaryot Microbiol 69:e12881
Saygi G (1969) Naegleria gruberi—a pathogen? Lancet 2:273
Ženíšková K, Grechnikova M, Sutak R (2022) Copper metabolism in Naegleria gruberi and its deadly relative Naegleria fowleri. Front Cell Dev Biol 10:853463
Fulton C (1977) Cell differentiation in Naegleria gruberi. Annu Rev Microbiol 31:597–629
Fritz-Laylin LK, Assaf ZJ, Chen S, Cande WZ (2010) Naegleria gruberi de novo basal body assembly occurs via stepwise incorporation of conserved proteins. Eukaryot Cell 9:860–865
Lee J (2010) De novo formation of basal bodies during cellular differentiation of Naegleria gruberi: progress and hypotheses. Semin Cell Dev Biol 21:156–162
Baig AM, Khan NA (2015) Tackling infection owing to brain-eating amoeba. Acta Trop 142:86–88
Harris GR, Batra R (2020) Naegleria fowleri. N Engl J Med 383:1057
Cope JR, Ratard RC, Hill VR, Sokol T, Causey JJ, Yoder JS, Mirani G, Mull B, Mukerjee KA, Narayanan J, Doucet M, Qvarnstrom Y, Poole CN, Akingbola OA, Ritter JM, Xiong Z, da Silva AJ, Roellig D, Van Dyke RB, Stern H, Xiao L, Beach MJ (2015) The first association of a primary amebic meningoencephalitis death with culturable Naegleria fowleri in tap water from a US treated public drinking water system. Clin Infect Dis 60:e36-42
Üstüntürk-Onan M, Walochnik J (2018) Identification of free-living amoebae isolated from tap water in Istanbul, Turkey. Exp Parasitol 195:34–37
Sowerby LJ, Wright ED (2012) Tap water or “sterile” water for sinus irrigations: what are our patients using? Int Forum Allergy Rhinol 2:300–302
Centers for Disease Control and Prevention (CDC) (2013) Notes from the field: primary amebic meningoencephalitis associated with ritual nasal rinsing—St. Thomas, U.S. Virgin Islands, 2012. MMWR Morb Mortal Wkly Rep 62:903
No authors stated (2014) Primary amebic meningoencephalitis associated with ritual nasal rinsing—St Thomas, US Virgin Islands, 2012. Clin Infect Dis 58:2
Levin S, Goodman LJ, Fuhrer J (1986) Fulminant community—acquired infectious diseases: diagnostic problems. Med Clin North Am 70:967–986
Bernard BK, Hubbs SA (2020) Extremely rare but deadly: brain-eating Naegleria fowleri amoeba in water. Water quality and health council. https://waterandhealth.org/safe-drinking-water/drinking-water/extremely-rare-but-deadly-brain-eating-naegleria-fowleri-amoeba-in-water/. Accessed June 13, 2023
Masaka E, Reed S, Davidson M, Oosthuizen J (2021) Opportunistic premise plumbing pathogens. A potential health risk in water mist systems used as a cooling intervention. Pathogens 10:462
Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Foodborne, Waterborne, and Environmental Disease (DFWED) (2023) Naegleria fowleri—primary amebic meningoencephalitis (PAM)—amebic encephalitis. Centers for Disease Control and Prevention. https://www.cdc.gov/parasites/naegleria/general.html. Accessed June 13, 2023
Weber N (2016) Ein rätselhafter Patient: Gefahr im Pool. Der Spiegel. https://www.spiegel.de/gesundheit/diagnose/meningitis-aus-dem-swimmingpool-ein-raetselhafter-patient-a-1091873.html. Accessed June 13, 2023
Shute N (2011) Your health: to avoid brain-eating amoebas, hold your nose. NPR. https://www.npr.org/sections/health-shots/2011/08/19/139781956/hold-your-nose-to-avoid-brain-eating-amoebas. Accessed June 13, 2023.
Baig AM (2016) Primary amoebic meningoencephalitis preventive nose plugs: prophylaxis against Naegleria fowleri. J Med Devices 10:014501
Kramer MH, Lerner CJ, Visvesvara GS (1997) Kidney and liver transplants from a donor infected with Naegleria fowleri. J Clin Microbiol 35:1032–1033
Roy SL, Metzger R, Chen JG, Laham FR, Martin M, Kipper SW, Smith LE, Lyon GM 3rd, Haffner J, Ross JE, Rye AK, Johnson W, Bodager D, Friedman M, Walsh DJ, Collins C, Inman B, Davis BJ, Robinson T, Paddock C, Zaki SR, Kuehnert M, DaSilva A, Qvarnstrom Y, Sriram R, Visvesvara GS (2014) Risk for transmission of Naegleria fowleri from solid organ transplantation. Am J Transplant 14:163–171
Shariq A, Afridi FI, Farooqi BJ, Ahmed S, Hussain A (2014) Fatal primary meningoencephalitis caused by Naegleria fowleri. J Coll Physicians Surg Pak 24:523–525
Gupta R, Parashar MK, Kale A (2015) Primary amoebic meningoencephalitis. J Assoc Physicians India 63:69–71
Nicholls CL, Parsonson F, Gray LE, Heyer A, Donohue S, Wiseman G, Norton R (2016) Primary amoebic meningoencephalitis in North Queensland: the paediatric experience. Med J Aust 205:325–328
Gharpure R, Bliton J, Goodman A, Ali IKM, Yoder J, Cope JR (2021) Epidemiology and clinical characteristics of primary amebic meningoencephalitis caused by Naegleria fowleri: a global review. Clin Infect Dis 73:e19–e27
Kemble SK, Lynfield R, DeVries AS, Drehner DM, Pomputius WF 3rd, Beach MJ, Visvesvara GS, da Silva AJ, Hill VR, Yoder JS, Xiao L, Smith KE, Danila R (2012) Fatal Naegleria fowleri infection acquired in Minnesota: possible expanded range of a deadly thermophilic organism. Clin Infect Dis 54:805–809
Capewell LG, Harris AM, Yoder JS, Cope JR, Eddy BA, Roy SL, Visvesvara GS, Fox LM, Beach MJ (2015) Diagnosis, clinical course, and treatment of primary amoebic meningoencephalitis in the United States, 1937–2013. J Pediatric Infect Dis Soc 4:e68–e75
RKI (2015) Amöbenenzephalitis. Robert Koch-Institut. https://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Amoebenenzephalitis.html. Accessed June 20, 2023
Matanock A, Mehal JM, Liu L, Blau DM, Cope JR (2018) Estimation of undiagnosed Naegleria fowleri primary amebic meningoencephalitis, United States1. Emerg Infect Dis 24:162–164
Boakye-Agyemang C (2022) Why do neglected tropical diseases suffer low priority? reliefweb. https://reliefweb.int/report/world/why-do-neglected-tropical-diseases-suffer-low-priority. Accessed June 13, 2023
Moseman EA (2020) Battling brain-eating amoeba: enigmas surrounding immunity to Naegleria fowleri. PLoS Pathog 16:e1008406
Rojas-Hernández S, Jarillo-Luna A, Rodríguez-Monroy M, Moreno-Fierros L, Campos-Rodríguez R (2004) Immunohistochemical characterization of the initial stages of Naegleria fowleri meningoencephalitis in mice. Parasitol Res 94:31–36
Best AM, Abu Kwaik Y (2019) Evasion of phagotrophic predation by protist hosts and innate immunity of metazoan hosts by Legionella pneumophila. Cell Microbiol 21:e12971
Cervantes-Sandoval I, Serrano-Luna J, García-Latorre E, Tsutsumi V, Shibayama M (2008) Characterization of brain inflammation during primary amoebic meningoencephalitis. Parasitol Int 57:307–313
Dance A (2019) Core concept: cells nibble one another via the under-appreciated process of trogocytosis. Proc Natl Acad Sci USA 116:17608–17610
Jassam YN, Izzy S, Whalen M, Mcgavern DB, El Khoury J (2017) Neuroimmunology of traumatic brain injury: time for a paradigm shift. Neuron 95:1246–1265
Ferrante A, Mocatta TJ (1984) Human neutrophils require activation by mononuclear leucocyte conditioned medium to kill the pathogenic free-living amoeba, Naegleria fowleri. Clin Exp Immunol 56:559–566
Michelson MK, Henderson WR, Chi EY, Fritsche TR, Klebanoff SJ (1990) Ultrastructural studies on the effect of tumor necrosis factor on the interaction of neutrophils and Naegleria fowleri. Am J Trop Med Hyg 42:225–233
Ferrante A, Lederer E (1986) Curative properties of muramyl dipeptide in experimental Naegleria meningoencephalitis. Trans R Soc Trop Med Hyg 80:323–326
Marciano-Cabral F, Cabral GA (2007) The immune response to Naegleria fowleri amebae and pathogenesis of infection. FEMS Immunol Med Microbiol 51:243–259
Shibayama M, Serrano-Luna J, Rojas-Hernández S, Campos-Rodríguez R, Tsutsumi V (2003) Interaction of secretory immunoglobulin A antibodies with Naegleria fowleri trophozoites and collagen type I. Can J Microbiol 49:164–170
Reilly MF, Marciano-Cabral F, Bradley DW, Bradley SG (1983) Agglutination of Naegleria fowleri and Naegleria gruberi by antibodies in human serum. J Clin Microbiol 17:576–581
Cerutti A, Cols M, Puga I (2013) Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes. Nat Rev Immunol 13:118–132
Lee J, Yoo JK, Sohn HJ, Kang HK, Kim D, Shin HJ, Kim JH (2015) Protective immunity against Naegleria fowleri infection on mice immunized with the rNfa1 protein using mucosal adjuvants. Parasitol Res 114:1377–1385
Carrasco-Yepez M, Rojas-Hernandez S, Rodriguez-Monroy M, Terrazas L, Moreno-Fierros L (2010) Protection against Naegleria fowleri infection in mice immunized with Cry1Ac plus amoebic lysates is dependent on the STAT6 Th2 response. Parasite Immunol 32:664–670
Walochnik J, Aspöck H (2005) Die Diagnostik von Infektionen mit freilebenden Amöben (FLA). LaboratoriumsMedizin 29:446–456
Kilvington S, Beeching J (1995) Identification and epidemiological typing of Naegleria fowleri with DNA probes. Appl Environ Microbiol 61:2071–2078
Hamill RJ (2013) Amphotericin B formulations: a comparative review of efficacy and toxicity. Drugs 73:919–934
Kumari S, Kumar V, Kumar Tiwari R, Ravidas V, Pandey K, Kumar A (2022) Amphotericin B: a drug of choice for visceral leishmaniasis. Acta Trop 235:106661
Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Foodborne, Waterborne, and Environmental Diseases (DFWED) (2023) Naegleria fowleri—primary Amebic meningoencephalitis (PAM)—Amebic encephalitis. Treatment. Centers for Disease Control and Prevention. https://www.cdc.gov/parasites/naegleria/treatment.html. Accessed June 20, 2023.
Grace E, Asbill S, Virga K (2015) Naegleria fowleri: pathogenesis, diagnosis, and treatment options. Antimicrob Agents Chemother 59:6677–6681
Russell AC, Kyle DE (2022) Differential growth rates and In Vitro drug susceptibility to currently used drugs for multiple isolates of Naegleria fowleri. Microbiol Spectr 10:e0189921
Siddiqui R, Mungroo MR, Anuar TS, Alharbi AM, Alfahemi H, Elmoselhi AB, Khan NA (2022) Antiamoebic properties of laboratory and clinically used drugs against Naegleria fowleri and Balamuthia mandrillaris. Antibiotics (Basel) 11:749
Debnath A, Nelson AT, Silva-Olivares A, Shibayama M, Siegel D, McKerrow JH (2018) In vitro efficacy of Ebselen and BAY 11–7082 against Naegleria fowleri. Front Microbiol 9:414
Rajendran K, Anwar A, Khan NA, Shah MR, Siddiqui R (2019) trans-Cinnamic acid conjugated gold nanoparticles as potent therapeutics against brain-eating amoeba Naegleria fowleri. ACS Chem Neurosci 10:2692–2696
Pugh JJ, Levy RA (2016) Naegleria fowleri: diagnosis, pathophysiology of brain inflammation, and antimicrobial treatments. ACS Chem Neurosci 7:1178–1179
Anderson CM, Joseph C, Fisher R, Berry D, Diestelhorst JB, Kulstad C, Wayne M (2022) Targeted temperature management using esophageal cooling. Ther Hypothermia Temp Manag 12:235–239
Kaylor HL, Wiencek C, Hundt E (2022) Targeted temperature management: a program evaluation. AACN Adv Crit Care 33:38–52
Diaz J (2018) Teen who survived brain-eating amoeba says sickness gave him more outlook. SunSentinel. https://www.sun-sentinel.com/2018/07/21/teen-who-survived-brain-eating-amoeba-says-sickness-gave-him-more-positive-outlook/. Accessed Juen 20, 2023.
Ženíšková K, Mach J, Arbon D, Štursa J, Werner L, Zoltner M, Sutak R (2023) The 4-aminomethylphenoxy-benzoxaborole AN3057 as a potential treatment option for primary amoebic meningoencephalitis. Antimicrob Agents Chemother 67:e0150622
Sharma S, Kumar D, Singh G, Monga V, Kumar B (2020) Recent advancements in the development of heterocyclic anti-inflammatory agents. Eur J Med Chem 200:112438
Sallam ER, Aboulnaga SF, Samy AM, Beltagy DM, El Desouky JM, Abdel-Hamid H, Fetouh HA (2023) Synthesis, characterization of new heterocyclic compound: pyrazolyl hydrazine quinoxaline derivative: 3-[5-(hydroxy1methyl)-1-phenylpyrazol-3-yl]-2-[2, 4, 5-trimethoxybenzylidine] hydrazonyl-quinoxaline of potent antimicrobial, antioxidant, antiviral, and antitumor activity. J Mol Struct 1271:133983
Fetouh HA, Abd-Elnaby HM, Alsubaie MS, Sallam ER (2022) New experimental low-cost nanoscience technology for formulation of silver nanoparticles-activated carbon composite as a promising antiviral, biocide, and efficient catalyst. J Exp Nanosci 17:297–314
Almufarij RS, Ali AE, Elbah ME, Elmaghraby NS, Khashaba MA, Abdel-Hamid H, Fetouh HA (2023) Preparation, characterization of new antimicrobial antitumor hybrid semi-organic single crystals of proline amino acid doped by silver nanoparticles. Biomedicines 11:360
Dkhil MA, Abdel-Gaber R, Alojaryi G, Al-Shaebi EM, Qasem MAA, Murshed M, Mares MM, El-Matbouli M, Al-Quraishy S (2020) Biosynthesized silver nanoparticles protect against hepatic injury induced by murine blood-stage malaria infection. Environ Sci Pollut Res Int 27:17762–17769
Rajendran K, Anwar A, Khan NA, Siddiqui R (2017) Brain-eating amoebae: silver nanoparticle conjugation enhanced efficacy of anti-amoebic drugs against Naegleria fowleri. ACS Chem Neurosci 8:2626–2630
Gutiérrez-Sánchez M, Carrasco-Yépez MM, Correa-Basurto J, Ramírez-Salinas GL, Rojas-Hernández S (2023) Two MP2CL5 antigen vaccines from Naegleria fowleri stimulate the immune response against meningitis in the BALB/c model. Infect Immun 91:e0018123
Nouailles G, Adler JM, Pennitz P, Peidli S, Teixeira Alves LG, Baumgardt M, Bushe J, Voss A, Langenhagen A, Langner C, Martin Vidal R, Pott F, Kazmierski J, Ebenig A, Lange MV, Mühlebach MD, Goekeri C, Simmons S, Xing N, Abdelgawad A, Herwig S, Cichon G, Niemeyer D, Drosten C, Goffinet C, Landthaler M, Blüthgen N, Wu H, Witzenrath M, Gruber AD, Praktiknjo SD, Osterrieder N, Wyler E, Kunec D, Trimpert J (2023) Live-attenuated vaccine sCPD9 elicits superior mucosal and systemic immunity to SARS-CoV-2 variants in hamsters. Nat Microbiol 8:860–874
Cooper AM, Aouthmany S, Shah K, Rega PP (2019) Killer amoebas: primary amoebic meningoencephalitis in a changing climate. JAAPA 32:30–35
Maciver SK, Piñero JE, Lorenzo-Morales J (2020) Is Naegleria fowleri an emerging parasite? Trends Parasitol 36:19–28
Goldenfeld N, Pace NR, Carl R (2013) Woese (1928–2012). Science 339:661
Funding
Open Access funding enabled and organized by Projekt DEAL.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Borkens, Y. The Pathology of the Brain Eating Amoeba Naegleria fowleri. Indian J Microbiol (2024). https://doi.org/10.1007/s12088-024-01218-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12088-024-01218-5